Valuation: Haleon plc

Market Cap 33.55B 44.57B 39.13B 36.52B 62.86B 4,273B 63.89B 432B 169B 2,112B 167B 164B 7,304B P/E 2026 *
19.7x
P/E 2027 * 17.8x
Enterprise Value 40.47B 53.76B 47.2B 44.05B 75.82B 5,153B 77.05B 521B 204B 2,547B 202B 197B 8,809B EV / Sales 2026 *
3.55x
EV / Sales 2027 * 3.36x
Free-Float
99.42%
Yield 2026 *
2.1%
Yield 2027 * 2.33%
1 day+2.89%
1 week+2.67%
Current month+9.55%
1 month+9.36%
3 months+8.74%
6 months+1.14%
Current year+1.63%
1 week 358.4
Extreme 358.4
384.2
1 month 344.2
Extreme 344.2
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Buy 24,891 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%+2.67%+4.21%+12.94% 43.39B
+1.93%+6.43%+50.20%+168.28% 1,068B
+0.29%+7.20%+58.48%+53.57% 641B
+2.45%+3.88%+38.32%+76.82% 454B
+2.17%+10.91%+41.94%+35.03% 351B
+1.46%+5.93%+40.44%+43.69% 299B
+0.40%+4.52%+19.79%+20.93% 266B
+2.73%+2.26%-25.81%-36.98% 220B
+4.48%+7.94%+28.22%+66.53% 203B
+2.91%+0.83%+15.59%+75.56% 162B
Average +1.38%+2.46%+27.14%+51.64% 370.67B
Weighted average by Cap. +0.79%+2.81%+38.67%+80.40%

Financials

2026 *2027 *
Net sales 11.4B 15.14B 13.29B 12.41B 21.36B 1,452B 21.71B 147B 57.5B 717B 56.79B 55.61B 2,481B 11.89B 15.8B 13.87B 12.94B 22.28B 1,514B 22.64B 153B 59.98B 748B 59.24B 58.01B 2,588B
Net income 1.74B 2.32B 2.03B 1.9B 3.27B 222B 3.32B 22.43B 8.79B 110B 8.68B 8.5B 379B 1.9B 2.53B 2.22B 2.07B 3.56B 242B 3.62B 24.46B 9.59B 120B 9.47B 9.27B 414B
Net Debt 6.91B 9.18B 8.06B 7.53B 12.95B 880B 13.16B 88.98B 34.87B 435B 34.45B 33.73B 1,505B 6.4B 8.51B 7.47B 6.97B 12B 815B 12.19B 82.42B 32.3B 403B 31.91B 31.24B 1,394B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-28 GBX 380.90 +2.89% 29,790,922
26-07-27 GBX 370.20 +1.84% 24,375,691
26-07-24 GBX 363.50 +0.53% 12,865,658
26-07-23 GBX 361.60 -1.18% 15,272,042
26-07-22 GBX 365.90 -0.73% 20,492,365
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.809GBP
Average target price
4.142GBP
Spread / Average Target
+8.75%

Quarterly revenue - Rate of surprise